Literature DB >> 1681779

Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.

J H Kordower1, E Cochran, R D Penn, C G Goetz.   

Abstract

We report heretofore undescribed clinical and histological features of a patient with idiopathic Parkinson's disease who showed marked and persistent motoric benefit from an adrenal medulla autograft for 18 months following grafting. The patient returned to the preoperative level of disability prior to his death 30 months after implantation, the longest survival to date for an adrenal transplant. The graft site was primarily necrotic and large numbers of macrophages were still present at the time of death. A few tyrosine hydroxylase-immunoreactive cells were found within the graft, providing the first evidence that adrenal medullary cells may be viable and produce catecholamines following human transplantation. A dense network of tyrosine hydroxylase-immunoreactive terminals and processes was also seen ventral to the implant site and on both of its lateral borders. This response may represent sprouting by residual host dopaminergic neurons mediated by the vigorous response to injury displayed by the host striatum. The relative paucity of surviving chromaffin cells, however, provides further evidence that adrenal medulla grafts survive poorly following intracerebral implantation, and factors other than dopamine replacement may be responsible for most of the functional effects observed following chromaffin cell transplantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681779     DOI: 10.1002/ana.410290411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

Authors:  E F Espejo; M C Gonzalez-Albo; J P Moraes; F El Banoua; J A Flores; I Caraballo
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.

Authors:  Hong Qu Yan; Xiecheng Ma; Xiangbai Chen; Youming Li; Lifang Shao; C Edward Dixon
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

Review 3.  A scientific rationale for protective therapy in Parkinson's disease.

Authors:  C W Olanow
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern.

Authors:  L Björklund; I Strömberg
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

5.  Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.

Authors:  P E Batchelor; G T Liberatore; J Y Wong; M J Porritt; F Frerichs; G A Donnan; D W Howells
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

6.  Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra.

Authors:  F C Zhou; Y H Chiang; Y Wang
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

Review 7.  Cell transplantation for Parkinson's disease: present status.

Authors:  René Drucker-Colín; Leticia Verdugo-Díaz
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

Review 8.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

Review 9.  Evidence for plasticity of the dopaminergic system in parkinsonism.

Authors:  G A Donnan; D G Woodhouse; S J Kaczmarczyk; J E Holder; G Paxinos; P J Chilco; A J Churchyard; R M Kalnins; G C Fabinyi; F A Mendelsohn
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 10.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.